Insights and Stories on Bayer

Apr. 17, 2025 at 10:03 am CDT

Bayer is lobbying U.S. states to adjust their regulatory framework in its battle to wind down costly litigation over its weed killer glyphosate, the German chemicals company's CEO said in a draft speech released on Thursday.

By Reuters

Apr. 16, 2025 at 1:16 pm CDT

Multiple law firms across the country – in Saskatchewan, Ontario, British Columbia and elsewhere – are now recruiting Canadians to join a class action lawsuit related to Roundup and cases of non-Hodgkin’s lymphoma.

By Robert Arnason

Apr. 4, 2025 at 2:11 pm CDT

Bayer said on Friday it was again petitioning the U.S. Supreme Court to sharply limit legal claims that its Roundup herbicide causes cancer, seeking to avoid potentially billions of dollars in damages.

By Brendan Pierson, Ludwig Burger, Reuters

Mar. 24, 2025 at 10:51 am CDT

Bayer was ordered by a jury in the U.S. state of Georgia to pay about $2.1 billion (C$3.01 billion) to a plaintiff who claimed the company's Roundup weed killer caused his cancer, the plaintiff's law firms said late on Friday.

By Reuters

Mar. 7, 2025 at 9:03 am CST

Bayer has told U.S. lawmakers it could stop selling Roundup weedkiller unless they can strengthen legal protection against product liability litigation.

By Ludwig Burger, Patricia Weiss, Reuters